Authors:
ZEIMET AG
OFFNER FA
MULLERHOLZNER E
WIDSCHWENDTER M
ABENDSTEIN B
FUITH LC
DAXENBICHLER G
MARTH C
Citation: Ag. Zeimet et al., PERITONEUM AND TISSUES OF THE FEMALE REPRODUCTIVE-TRACT AS PHYSIOLOGICAL SOURCES OF CA-125, Tumor biology, 19(4), 1998, pp. 275-282
Citation: C. Marth et al., 10-YEAR RESULTS OF A RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN AND CYCLOPHOSPHAMIDE IN ADVANCED, SUBOPTIMALLY DEBULKED OVARIAN-CANCER, European journal of cancer, 34(8), 1998, pp. 1175-1180
Authors:
ZEIMET AG
WIDSCHWENDTER M
DAXENBICHLER G
SKOVLUND E
MARTH C
Citation: Ag. Zeimet et al., IS ASCITIC FLUID INTERLEUKIN-12 AN INDEPENDENT PROGNOSTIC FACTOR IN OVARIAN-CANCER - THE NECESSITY OF CORRECTION MILLIGRAM P VALUES FOR MULTIPLE COMPARISONS - REPLY, Journal of clinical oncology, 16(9), 1998, pp. 3208-3209
Authors:
ZEIMET AG
WIDSCHWENDTER M
KNABBE C
FUCHS D
HEROLD M
MULLERHOLZNER E
DAXENBICHLER G
OFFNER FA
DAPUNT O
MARTH C
Citation: Ag. Zeimet et al., ASCITIC INTERLEUKIN-12 IS AN INDEPENDENT PROGNOSTIC FACTOR IN OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1861-1868
Authors:
MEISTER B
FINK FM
HITTMAIR A
MARTH C
WIDSCHWENDTER M
Citation: B. Meister et al., ANTIPROLIFERATIVE ACTIVITY AND APOPTOSIS INDUCED BY RETINOIC ACID RECEPTOR-GAMMA SELECTIVELY BINDING RETINOIDS IN NEUROBLASTOMA, Anticancer research, 18(3A), 1998, pp. 1777-1786
Authors:
JENTSCHKE G
MARSCHNER P
VODNIK D
MARTH C
BREDEMEIER M
RAPP C
FRITZ E
GOGALA N
GODBOLD DL
Citation: G. Jentschke et al., LEAD UPTAKE BY PICEA-ABIES SEEDLINGS - EFFECTS OF NITROGEN-SOURCE ANDMYCORRHIZAS, Journal of plant physiology, 153(1-2), 1998, pp. 97-104
Citation: C. Marth et al., TAMOXIFEN IN THE TREATMENT OF RECURRENT OVARIAN-CARCINOMA, International journal of gynecological cancer, 7(4), 1997, pp. 256-261
Authors:
ZEIMET AG
OFFNER FA
MARTH C
HEIM K
FEICHTINGER H
DAXENBICHLER G
DAPUNT O
Citation: Ag. Zeimet et al., MODULATION OF CA-125 RELEASE BY INFLAMMATORY CYTOKINES IN HUMAN PERITONEAL MESOTHELIAL AND OVARIAN-CANCER CELLS, Anticancer research, 17(4B), 1997, pp. 3129-3131
Authors:
KURZ C
MARTH C
WINDBICHLER G
LAHOUSEN M
MEDL M
VAVRA N
SEVELDA P
Citation: C. Kurz et al., ERYTHROPOIETIN TREATMENT UNDER POLYCHEMOTHERAPY IN PATIENTS WITH GYNECOLOGIC MALIGNANCIES - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY, Gynecologic oncology, 65(3), 1997, pp. 461-466
Authors:
VOLGGER B
MARTH C
ZEIMET A
MULLERHOLZNER E
RUTH N
DAPUNT O
Citation: B. Volgger et al., FULMINANT COURSE OF A MICROINVASIVE VULVAR CARCINOMA IN AN IMMUNOSUPPRESSED WOMAN, Gynecologic oncology, 65(1), 1997, pp. 177-179
Authors:
MARTH C
WINDBICHLER G
PETRU E
DIRSCHLMAYER W
OBERMAIR A
CZERWENKA K
MULLERHOLZNER E
DAPUNT O
Citation: C. Marth et al., PARITY AS AN INDEPENDENT PROGNOSTIC FACTOR IN MALIGNANT MIXED MESODERMAL TUMORS OF THE ENDOMETRIUM, Gynecologic oncology, 64(1), 1997, pp. 121-125
Authors:
WIDSCHWENDTER M
DAXENBICHLER G
CULIG Z
MICHEL S
ZEIMET AG
MORTL MG
WIDSCHWENDTER A
MARTH C
Citation: M. Widschwendter et al., ACTIVITY OF RETINOIC ACID RECEPTOR-GAMMA SELECTIVELY BINDING RETINOIDS ALONE AND IN COMBINATION WITH INTERFERON-GAMMA IN BREAST-CANCER CELL-LINES, International journal of cancer, 71(3), 1997, pp. 497-503
Authors:
WIDSCHWENDTER M
BERGER J
DAXENBICHLER G
MULLERHOLZNER E
WIDSCHWENDTER A
MAYR A
MARTH C
ZEIMET AG
Citation: M. Widschwendter et al., LOSS OF RETINOIC ACID RECEPTOR-BETA EXPRESSION IN BREAST-CANCER AND MORPHOLOGICALLY NORMAL ADJACENT TISSUE BUT NOT IN THE NORMAL BREAST-TISSUE DISTANT FROM THE CANCER, Cancer research, 57(19), 1997, pp. 4158-4161
Authors:
MARTH C
ZEIMET AG
WIDSCHWENDTER M
LUDESCHER C
KAERN J
TROPE C
GASTL G
DAXENBICHLER G
DAPUNT O
Citation: C. Marth et al., PACLITAXEL-DEPENDENT AND DOCETAXEL-DEPENDENT ACTIVATION OF CA-125 EXPRESSION IN HUMAN OVARIAN-CARCINOMA CELLS, Cancer research, 57(17), 1997, pp. 3818-3822
Authors:
ZEIMET AG
WIDSCHWENDTER M
UHLSTEIDL M
MULLERHOLZNER E
DAXENBICHLER G
MARTH C
DAPUNT O
Citation: Ag. Zeimet et al., HIGH SERUM LEVELS OF SOLUBLE CD44 VARIANT ISOFORM V5 ARE ASSOCIATED WITH FAVORABLE CLINICAL OUTCOME IN OVARIAN-CANCER, British Journal of Cancer, 76(12), 1997, pp. 1646-1651
Authors:
MARTH C
WIDSCHWENDTER M
KAERN J
JORGENSEN NP
WINDBICHLER G
ZEIMET AG
TROPE C
DAXENBICHLER G
Citation: C. Marth et al., CISPLATIN RESISTANCE IS ASSOCIATED WITH REDUCED INTERFERON-GAMMA-SENSITIVITY AND INCREASED HER-2 EXPRESSION IN CULTURED OVARIAN-CARCINOMA CELLS, British Journal of Cancer, 76(10), 1997, pp. 1328-1332
Authors:
VOLGGER B
ALGE A
WINDBICHLER G
ZEIMET AG
MULLERHOLZNER E
MARTH C
Citation: B. Volgger et al., ASSESSMENT OF THE POSTMENOPAUSAL ENDOMETR IUM BY TRANSVAGINAL SONOGRAPHY - A PROSPECTIVE-STUDY, Gynakologisch-geburtshilfliche Rundschau, 36(1), 1996, pp. 21-28
Authors:
ZEIMET AG
MARTH C
FUCHS D
HEROLD M
WIDSCHWENDTER M
DAXENBICHLER G
IACOBELLI S
DAPUNT O
Citation: Ag. Zeimet et al., PROTEIN 90K STIMULATES THE IMMUNE-SYSTEM IN OVARIAN-CANCER, Gynakologisch-geburtshilfliche Rundschau, 36(1), 1996, pp. 44-45
Authors:
MULLERHOLZNER E
MARTH C
ZEIMET AG
HOFSTADTER F
DAXENBICHLER G
Citation: E. Mullerholzner et al., EFFECTS OF SEX AND GLUCOCORTICOID STEROIDS ON BREAST-CANCER CELLS GROWN AS EITHER MULTICELLULAR TUMOR SPHEROIDS OR MONOLAYERS, Journal of steroid biochemistry and molecular biology, 58(1), 1996, pp. 13-19
Authors:
OFFNER FA
FEICHTINGER H
STADLMANN S
OBRIST P
MARTH C
KLINGLER P
ABENDSTEIN B
GRAGE B
SCHMAHL M
KNABBE C
Citation: Fa. Offner et al., HUMAN PERITONEAL MESOTHELIAL CELLS SYNTHESIZE TRANSFORMING GROWTH-FACTOR-BETA ISOFORM-1 AND ISOFORM-2 - INDUCTION BY INTERLEUKIN-1, The FASEB journal, 10(3), 1996, pp. 4431-4431
Authors:
WIDSCHWENDTER M
DAXENBICHLER G
BACHMAIR F
MULLER E
ZEIMET AG
WINDBICHLER G
UHLSTEIDL M
LANG T
MARTH C
Citation: M. Widschwendter et al., INTERACTION OF RETINOIC ACID AND INTERFERON-ALPHA IN BREAST-CANCER CELL-LINES, Anticancer research, 16(1), 1996, pp. 369-374
Authors:
ZEIMET AG
MARTH C
OFFNER FA
OBRIST P
UHLSTEIDL M
FEICHTINGER H
STADLMANN S
DAXENBICHLER G
DAPUNT O
Citation: Ag. Zeimet et al., HUMAN PERITONEAL MESOTHELIAL CELLS ARE MORE POTENT THAN OVARIAN-CANCER CELLS IN PRODUCING TUMOR-MARKER CA-125, Gynecologic oncology, 62(3), 1996, pp. 384-389